• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS CA 19-9; CARBOHYDRATE ANTIGEN (CA19-9) TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS CA 19-9; CARBOHYDRATE ANTIGEN (CA19-9) TEST SYSTEM Back to Search Results
Catalog Number 07027028190
Medical Device Problem Codes High Test Results (2457); Non Reproducible Results (4029)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/21/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The e801 analyzer serial number was (b)(6).The sample was requested for investigation.
 
Event or Problem Description
The initial reporter complained of a high result not corresponding to the clinical picture for 1 patient sample tested for elecsys ca 19-9 (ca 19-9) on a cobas e 801 analytical unit.The result from the e801 analyzer was 101 u/ml.The repeat was 100 u/ml.The sample was repeated by an unspecified competitor method, and the result was 11.0 u/ml.The result of 11.0 u/ml was believed to be correct.
 
Additional Manufacturer Narrative
Calibration and qc were acceptable.No instrument alarms were observed for the ca 19-9 test.The sample was received for investigation.The customer's results were reproduced during the investigation.The sample was further investigated using a heterophilic blocking tube (hbt) and polyethylene glycol (peg).Macro-protein and heterophilic antibody interfering factors were identified.This interference is addressed in product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design." the investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS CA 19-9
Common Device Name
CARBOHYDRATE ANTIGEN (CA19-9) TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
MDR Report Key22806063
Report Number1823260-2025-02491
Device Sequence Number12676719
Product Code NIG
UDI-Device Identifier04015630939640
UDI-Public04015630939640
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K050231
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/30/2025
Device Catalogue Number07027028190
Device Lot Number78240801
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/25/2025
Supplement Date Received by Manufacturer08/26/2025
Initial Report FDA Received Date08/14/2025
Supplement Report FDA Received Date09/11/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-